In this study, we examined the role of FAM111B in ovarian cancer through in vitro and in vivo experiments, and our analysis of FAM111B protein levels in tissue microarray samples revealed a correlation between elevated FAM111B expression and unfavorable patient outcomes. The gene discussed is FAM111B; the disease is ovarian carcinoma.